The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 14, 2023

Filed:

Mar. 04, 2021
Applicant:

Autolus Limited, London, GB;

Inventors:

Martin Pulé, London, GB;

Leila Mekkaoui, London, GB;

Assignee:

AUTOLUS LIMITED, London, GB;

Attorney:
Primary Examiner:
Int. Cl.
CPC ...
C12N 15/86 (2006.01); C12N 15/867 (2006.01); C12N 5/0783 (2010.01); C12N 7/00 (2006.01); C12N 15/49 (2006.01); C07K 14/725 (2006.01); C07K 16/28 (2006.01); A61K 35/76 (2015.01); A61K 38/00 (2006.01); C07K 16/00 (2006.01); C07K 14/00 (2006.01); A61K 39/00 (2006.01);
U.S. Cl.
CPC ...
C12N 15/86 (2013.01); A61K 35/76 (2013.01); A61K 38/00 (2013.01); C07K 14/00 (2013.01); C07K 14/7051 (2013.01); C07K 16/00 (2013.01); C07K 16/2809 (2013.01); C07K 16/2818 (2013.01); A61K 2039/507 (2013.01); C07K 2317/622 (2013.01); C07K 2317/75 (2013.01); C12N 2740/13032 (2013.01); C12N 2740/13045 (2013.01); C12N 2740/13052 (2013.01); C12N 2740/15032 (2013.01); C12N 2740/15045 (2013.01); C12N 2740/15052 (2013.01); C12N 2810/852 (2013.01); C12N 2810/855 (2013.01); C12N 2810/859 (2013.01);
Abstract

The present invention provides a retroviral or lentiviral vector having a viral envelope which comprises: (i) a mitogenic T-cell activating transmembrane protein which comprises a mitogenic domain and a transmembrane domain; and/or (ii) a cytokine-based T-cell activating transmembrane protein which comprises a cytokine domain and a transmembrane domain, wherein the mitogenic or cytokine-based T-cell activating transmembrane protein is not part of a viral envelope glycoprotein. When cells such as T-cells of Natural Killer cells are transduced by such a viral vector, they are simultaneously activated by the mitogenic T-cell activating transmembrane protein and/or the cytokine-based T-cell activating transmembrane protein.


Find Patent Forward Citations

Loading…